BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 9559906)

  • 1. Characterization of prejunctional 5-HT1 receptors that mediate the inhibition of pressor effects elicited by sympathetic stimulation in the pithed rat.
    Morán A; Fernández MM; Velasco C; Martín ML; San Román L
    Br J Pharmacol; 1998 Mar; 123(6):1205-13. PubMed ID: 9559906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat.
    García M; Morán A; Calama E; Martín ML; Barthelmebs M; Román LS
    Br J Pharmacol; 2005 Jul; 145(5):593-601. PubMed ID: 15852039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of 5-hydroxytryptamine-induced inhibition on the pressor effect elicited by sympathetic stimulation in long-term diabetic pithed rats.
    Morán A; Restrepo B; de Urbina AV; García M; Martín ML; Román LS
    Eur J Pharmacol; 2010 Sep; 643(1):70-7. PubMed ID: 20547148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.
    Villalón CM; Centurión D; Rabelo G; de Vries P; Saxena PR; Sánchez-López A
    Br J Pharmacol; 1998 Jul; 124(5):1001-11. PubMed ID: 9692787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
    García M; Morán A; Martín ML; Ortizde Urbina AV; San Román L
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat.
    Villalón CM; Contreras J; Ramírez-San Juan E; Castillo C; Perusquía M; Terrón JA
    Br J Pharmacol; 1995 Dec; 116(8):3330-6. PubMed ID: 8719815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory 5-hydroxytryptamine receptors involved in pressor effects obtained by stimulation of sympathetic outflow from spinal cord in pithed rats.
    Morán A; Velasco C; Salvador T; Martín ML; San Román L
    Br J Pharmacol; 1994 Dec; 113(4):1358-62. PubMed ID: 7889292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.
    Sánchez-Lopez A; Centurión D; Vázquez E; Arulmani U; Saxena PR; Villalón CM
    Br J Pharmacol; 2003 Oct; 140(4):725-35. PubMed ID: 14504136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats.
    García M; Morán A; Luisa Martín M; Barthelmebs M; San Román L
    Eur J Pharmacol; 2006 May; 537(1-3):126-34. PubMed ID: 16630608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic 5-HT
    García-Pedraza JÁ; Hernández-Abreu O; García M; Morán A; Villalón CM
    Can J Physiol Pharmacol; 2018 Apr; 96(4):328-336. PubMed ID: 28886249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.
    García-Pedraza JÁ; García M; Martín ML; Morán A
    Vascul Pharmacol; 2015 Sep; 72():172-80. PubMed ID: 26003124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mechanisms involved in presynaptic inhibition of sympathetic pressor effects induced by some 5-HT1 receptor antagonists.
    Fernández MM; Calama E; Morán A; Martín ML; San Román L
    J Auton Pharmacol; 2000; 20(5-6):313-23. PubMed ID: 11350497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
    García-Pedraza JÁ; García M; Martín ML; Gómez-Escudero J; Rodríguez-Barbero A; Román LS; Morán A
    Eur J Pharmacol; 2013 Aug; 714(1-3):65-73. PubMed ID: 23769743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling the pharmacological profile of the canine external carotid vasodilator '5-HT1-like' receptors: coexistence of sympatho-inhibitory 5-HT1B and postjunctional 5-HT7 receptors.
    Villalón CM; Sánchez-López A; Centurión D; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):73-80. PubMed ID: 11191839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
    Lozano-Cuenca J; Muñoz-Islas E; González-Hernández A; Centurión D; Cobos-Puc LE; Sánchez-López A; Pertz HH; Villalón CM
    Eur J Pharmacol; 2009 Jun; 612(1-3):80-6. PubMed ID: 19356724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats.
    García-Pedraza JÁ; García M; Martín ML; San Román L; Morán A
    Eur J Pharmacol; 2014 May; 731():80-7. PubMed ID: 24675150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
    Calama E; Ortíz de Urbina AV; Morán A; Martín ML; San Román L
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):894-900. PubMed ID: 16173953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of the 5-HT1 receptors mediating cardiac sympatho-inhibition in pithed rats: pharmacological correlation with the 5-HT1B and 5-HT1D subtypes.
    Sánchez-López A; Centurión D; Vázquez E; Arulmani U; Saxena PR; Villalón CM
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):220-7. PubMed ID: 14673512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evidence that 5-HT1A/1B/1D, α2-adrenoceptors and D2-like receptors mediate ergotamine-induced inhibition of the vasopressor sympathetic outflow in pithed rats.
    Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Gutiérrez-Lara EJ; Centurión D
    Eur J Pharmacol; 2014 Oct; 740():512-21. PubMed ID: 24975101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.
    González-Hernández A; Manrique-Maldonado G; Lozano-Cuenca J; Muñoz-Islas E; Centurión D; Maassen VanDenBrink A; Villalón CM
    Eur J Pharmacol; 2011 Jun; 659(2-3):233-43. PubMed ID: 21473863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.